Novel role of red wine-derived polyphenols in the prevention of Alzheimer's disease dementia and brain pathology: Experimental approaches and clinical implications

Planta Medica

Volumn 78, Issue 15, 2012, Pages 1614-1619

  Pasinetti, Giulio Maria ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimers disease; grape; polyphenols; Vitaceae; Vitis rotundifolia

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; CATECHIN; COUMESTROL; ENTEROLACTONE; EPICATECHIN; GAMMA SECRETASE; GENISTEIN; GLUCURONIDE; GRAPE SEED EXTRACT; LUTEOLIN; MYRICETIN; NARINGENIN; OLIGOMER; POLYPHENOL DERIVATIVE; PROANTHOCYANIDIN B1; PROANTHOCYANIDIN DERIVATIVE; RESVERATROL; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; DEMENTIA; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG ACTIVITY; DRUG BIOAVAILABILITY; GRAPE; HIPPOCAMPUS; HUMAN; HYPOTHESIS; IN VITRO STUDY; LIFESTYLE MODIFICATION; MENTAL DETERIORATION; MISSENSE MUTATION; NERVE CELL CULTURE; NERVE CELL PLASTICITY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PROPHYLAXIS; PROTEIN AGGREGATION; RED WINE; REVIEW; RISK FACTOR; TAUOPATHY; VITIS;

VITACEAE; VITIS ROTUNDIFOLIA;

EID: 84867847361     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0032-1315377     Document Type: Review

References (49)

1. Alzheimers Association 2008 Alzheimers disease facts and figures. Alzheimers & Dementia: 2008; 4 110 133
2. Cummings J. L. Treatment of Alzheimers disease: current and future therapeutic approaches. Rev Neurol Dis: 2004; 1 60 69
3. Duyckaerts C., Delatour B., Potier M. C. Classification and basic pathology of Alzheimers disease. Acta Neuropathol: 2009; 118 5 36
4. Davies P., Koppel J. Mechanism-based treatment for Alzheimers disease. Dialogues Clin Neurosci: 2009; 11 159 169
5. Bertram L., Tanzi R. E. Thirty years of Alzheimers disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci: 2008; 9 768 778
6. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T. D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., Younkin S. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimers disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimers disease. Nat Med: 1996; 2 864 870 (Pubitemid 26296755)
7. Duff K., Eckman C., Zehr C., Yu X., Prada C. M., Perez-tur J., Hutton M., Buee L., Harigaya Y., Yager D., Morgan D., Gordon M. N., Holcomb L., Refolo L., Zenk B., Hardy J., Younkin S. Increased amyloid- β 42(43) in brains of mice expressing mutant presenilin 1. Nature: 1996; 383 710 713 (Pubitemid 26360645)
8. Cleary J. P., Wash D. M., Hofmeister J. J., Shankar M., Kuskowski M. A., Selkoe D. J., Ashe K. H. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci: 2005; 8 79 84 (Pubitemid 41236735)
9. Jacobsen J. S., Wu C. C., Redwine J. M., Comery T. A., Arias R., Boxlby M., Martone R., Morrison J. H., Pangalos M. N., Reinhart P. H., Bloom F. E. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimers disease. Proc Natl Acad Sci USA: 2006; 103 5161 5166
10. Klyubin I., Walsh D. M., Lemere C. A., Cullen W. K., Shankar G. M., Betts V., Spooner E. T., Jiang L., Anwyl R., Selkoe D. J., Rowan M. J. Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticithy in vivo. Nat Med: 2005; 11 556 561 (Pubitemid 40685979)
11. Lesne S., Koh M. T., Kotilinek L., Kayed R., Glabe C. G., Yang A., Gallagher M., Ashe K. H. A specific amyloid-beta protein assembly in the brain impairs memory. Nature: 2005; 440 352 357
12. Walsh D. M., Klyubin I., Fadeeva J. V., Cullen W. K., Anwyl R., Wolfe M. S., Rowan M. J., Selkoe D. J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature: 2002; 416 535 539 (Pubitemid 34288854)
13. Hardy J., Selkoe D. J. The amyloid hypothesis of Alzheimers disease: progress and problems on the road to therapeutics. Science: 2002; 297 353 356 (Pubitemid 34790756)
14. Goedert M. Tau protein and the neurofibrillary pathology of Alzheimers disease. Ann NY Acad Sci: 1996; 77 121 131 (Pubitemid 26149179)
15. Sahara N., Maeda S., Takashima A. Tau oligomerization: a role for tau aggregation intermediates linked to neurodegeneration. Curr Alzheimer Res: 2008; 5 591 598
16. Berger Z., Roder H., Hanna A., Carlson A., Rangachari V., Yue M., Wszolek Z., Ashe K., Knight J., Dickson D., Andorfer C., Rosenberry T. L., Lewis J., Hutton M., Janus C. Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. J Neurosci: 2007; 27 3650 3652
17. Santacruz K., Lewis J., Spires T., Paulson J., Kotilinek L., Ingelsson M., Guimaraes A., Deture M., Ramsden M., McGowan E., Forster C., Yue M., Orne J., Janus C., Mariash A., Kuskowski M., Hyman B., Hutton M., Ashe K. H. Tau suppression in a neurodegenerative mouse model improves memory function. Science: 2005; 309 476 481 (Pubitemid 40994688)
18. Sorrentino G., Bonavita V. Neurodegeneration and Alzheimers disease: the lesson from tauopathies. Neurol Sci: 2007; 28 63 71 (Pubitemid 46681660)
19. Ramesh B. N., Rao T. S., Prakasam A., Sambamurti K., Rao K. S. Neuronutrition and Alzheimers disease. J Alzheimers Dis: 2010; 19 1123 1139
20. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits. A β elevation, and amyloid plaques in transgenic mice. Science: 1996; 274 99 102 (Pubitemid 26332733)
21. Brouillard R., George F., Fougerousse A. Polyphenols produced during red wine ageing. Biofactors: 1997; 6 403 410 (Pubitemid 27475626)
22. Cantos E., Espin J. C., Tomas-Barberan F. A. Varietal differences among the polyphenol profiles of seven table grape cultivars studied by LC-DAD-MS-MS. J Agric Food Chem: 2002; 50 5691 5696
23. De La Hera Orts M. L., Martinez-Cutillas A., Lopez Roca J. M., Perez-Prieto E., Gomez-Plaze E. Effect of deficit irrigation on anthocyanin content of Monastrell grapes and wines. J Int Sci Vigne Vin: 2005; 39 47 55 (Pubitemid 41480568)
24. Lee J. E., Hwang G. S., Van Den B. F., Lee C. H., Hong Y. S. Evidence of vintage effects on grape wines using 1H NMR-based metabolomic study. Anal Chim Acta: 2009; 648 71 76
25. Manach C., Scalbert A., Morand C., Rémésy C., Jiménez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr: 2004; 79 727 747 (Pubitemid 41103873)
26. Pérez-Jiménez J., Neveu V., Vos F., Scalbert A. Identification of the 100 richest dietary sources of polyphenols: an application of the Phenol-Explorer database. Eur J Clin Nutr: 2010; 64 03 S112 S120
27. Radovanovic B. C., Radovanovic A. N., Souquet J. M. Phenolic profile and free radical-scavenging activity of Cabernet Sauvignon wines of different geographical origins from the Balkan region. J Sci Food Agric: 2010; 90 2455 2461
28. Yokotsuka K., Nagao A., Nakazawa K., Sato M. Changes in anthocyanins in berry skins of Merlot and Cabernet Sauvignon grapes grown in two soils modified with limestone or oyster shell versus a native soil over two years. AmJ Enol Viticult: 1999; 50 1 12 (Pubitemid 29194884)
29. Xu Y., Simon J. E., Welch C., Wightman J. D., Ferruzzi M. G., Ho L., Passinetti G. M., Wu Q. Survey of polyphenol constituents in grapes and grape-derived products. J Agric Food Chem: 2011; 59 10586 10593
30. Barnes S., Prasain J., DAlessandro T., Arabshahi A., Botting N., Lila M. A., Jackson G., Janle E. M., Weaver C. M. The metabolism and analysis of isoflavones and other dietary polyphenols in foods and biological systems. Food Funct: 2011; 2 235 244
31. Wu Z., Ming J., Gao R., Wang Y., Liang Q., Yu H., Zhao G. Characterization and antioxidant activity of the complex of tea polyphenols and oat β -glucan. J Agric Food Chem: 2011; 59 10737 10746
32. Semalty A., Semalty M., Rawat M. S., Franceschi F. Supramolecular phospholipids-polyphenolics interactions: the PHYTOSOME strategy to improve the bioavailability of phytochemicals. Fitoterapia: 2010; 81 306 314
33. Monagas M., Urpi-Sarda M., Sánchez-Patán F., Llorach R., Garrido I., Gómez-Cordovés C., Andres-Lacueva C., Bartolomé B. Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites. Food Funct: 2010; 1 233 253
34. Ferruzzi M. G., Lobo J. K., Janle E. M., Cooper B., Simon J. E., Wu Q. L., Welch C., Ho L., Weaver C., Pasinetti G. M. Bioavailability of gallic acid and catechins from grape seed polyphenol extract is improved by repeated dosing in rats: implications for treatment in Alzheimers disease. J Alzheimers Dis: 2009; 18 113 124
35. Yang C. S., Sang S., Lambert J. D., Lee M. J. Bioavailability issues in studying the health effects of plant polyphenolic compounds. Mol Nutr Food Res: 2008; 52 01 S139 S151
36. Galli F. Interactions of polyphenolic compounds with drug disposition and metabolism. Curr Drug Metab: 2007; 8 830 838 (Pubitemid 350238913)
37. Silberberg M., Besson C., Manach C., Remesy C., Morand C. Influence of dietary antioxidants on polyphenol intestinal absorption and metabolism in rats. J Agric Food Chem: 2006; 54 3541 3546 (Pubitemid 43852829)
38. Lambert J. D., Hong J., Kim D. H., Mishin V. M., Yang C. S. Piperine enhances the bioavailability of the tea polyphenol ()-epigallocatechin-3-gallate in mice. J Nutr: 2004; 134 1948 1952 (Pubitemid 39031322)
39. Forester S. C., Waterhouse A. L. Metabolites are key to understanding health effects of wine polyphenolics. J Nutr: 2009; 139 1824S 1831S
40. Wang J., Ferruzzi M. G., Ho L., Blount J., Janle E. M., Gong B., Pan Y., Gowda G. A., Raftery D., Arrieta-Cruz I., Sharma V., Cooper B., Lobo J., Simon J. E., Zhang C., Cheng A., Qian X., Ono K., Teplow D. B., Pavlides C., Dixon R. A., Pasinetti G. M. Brain-targeted proanthocyanidin metabolites for Alzheimers disease treatment. J Neurosci: 2012; 32 5144 5150
41. Wang J., Ho L., Zhao W., Ono K., Rosensweig C., Chen L., Humala N., Teplow D. B., Pasinetti G. M. Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimers disease. J Neurosci: 2008; 28 6388 6392
42. Wang J., Ho L., Zhao Z., Seror I., Humala N., Dickstein D. L., Thiyagarajan M., Percival S. S., Talcott S. T., Pasinetti G. M. Moderate consumption of Cabernet Sauvignon attenuated beta-amyloid neuropathology in a mouse model of Alzheimer/s disease. FASEB J: 2006; 20 2313 2320 (Pubitemid 44953861)
43. Ho L., Chen L. H., Wang J., Zhao W., Talcott S. T., Ono K., Teplow D., Humala N., Cheng A., Percival S. S., Ferruzzi M., Janle E., Dickstein D. L., Pasinetti G. M. Heterogeneity in red wine polyphenolic contents differentially influences Alzheimers disease-type neuropathology and cognitive deterioration. J Alzheimers Dis: 2009; 16 59 72
44. Bitan G., Lomakin A., Teplow D. B. Amyloid beta-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins. J Biol Chem: 2001; 276 35176 35184
45. Pasinetti G. M., Wang J., Marambaud P., Ferruzzi M., Gregor P., Knable L. A., Ho L. Neuroprotective and metabolic effects of resveratrol: therapeutic implications for Huntingtons disease and other neurodegenerative disorders. Exp Neurol: 2011; 232 1 6
46. Marambaud P., Zhao H., Davies P. Resveratrol promotes clearance of Alzheimers disease amyloid- β peptides. J Biol Chem: 2005; 280 37377 37382 (Pubitemid 41642343)
47. Ho L., Pasinetti G. M. Polyphenolic compounds for treating neurodegenerative disorders involving protein misfolding. Expert Rev Proteomics: 2010; 7 579 589
48. Wang J., Santa-Maria I., Ho L., Ksiezak-Reding H., Ono K., Teplow D. B., Pasinetti G. M. Grape derived polyphenols attenuate tau neuropathology in a mouse model of Alzheimers disease. J Alzheimers Dis: 2010; 22 653 661
49. Santa-Maria I., Diaz-Ruiza C., Ksiezak-Reding H., Chen A., Ho L., Wang J., Pasinetti G. M. GSPE interferes with tau aggregation in vivo: implication for treating tauopathy. Neurobiol Aging: 2012; 33 2072 2081